Mundipharma
Global healthcare company with a portfolio of around 50 medicines in Pain Management, Oncology, Respiratory and Infectious Disease, operating across six regions.
Mundipharma is a global healthcare company that develops and delivers treatments across four therapeutic areas: Pain Management, Oncology, Respiratory and Infectious Disease. Its portfolio comprises approximately 50 primary and specialty care medicines. The company has been in operation for more than 60 years.
Geographically, Mundipharma operates across Africa, Asia Pacific, Canada, Europe, Latin America and the Middle East. It works with customers, patients and partners in these markets to bring its medicines to those who need them.
The company describes a culture anchored in guiding principles and behaviours, with integrity and patient-centricity at its centre. It positions people - customers and their patients, partners and its own teams - as central to its work, and states that every team member can contribute to improving patient outcomes.
Mundipharma encourages employees to think differently, embraces continuous learning and aims to foster collaboration. It says it continually challenges itself to deliver more for patients, healthcare professionals, partners and employees.
